Zerviate For Solution
NDC Package 82667-015-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Zerviate (cetirizine) for solutions is zERVIATE ®(cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis. This formulation utilizes a for solution delivery system. Marketed by Harrow Eye, Llc, this product is identified by NDC 82667-015 and is authorized under FDA application NDA208694.

Identification & Billing

NDC Package Code
82667-015-24
Package Description
1 POUCH in 1 CARTON / 30 VIAL, SINGLE-USE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-USE
Product Code
82667-015
11-Digit Billing Format
82667001524
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zerviate
Non-Proprietary Name
Cetirizine
Substance Name
Cetirizine
Dosage Form
For Solution - A product, usually a solid, intended for solution prior to administration.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
CETIRIZINE 2.4 mg/mL
Pharmacologic Class
Usage Information
ZERVIATE ®(cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Regulatory & Marketing

Labeler Name
Harrow Eye, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA208694
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-30-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82667-015-24 identifies a specific commercial package of 1 pouch in 1 carton / 30 vial, single-use in 1 pouch / 2.5 ml in 1 vial, single-use of Zerviate, a human prescription drug labeled by Harrow Eye, Llc. This for solution is formulated for ophthalmic use and contains cetirizine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Harrow Eye, Llc on April 30, 2025. The current certification is valid through December 31, 2026.

How is this Harrow Eye, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82667001524. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82667-015-24
11-Digit CMS (5-4-2)
82667-0015-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.